Return to Library
Persistent pulmonary hypertension of the newborn Visual Overview
SubcategoryNewborns
Topic

Persistent pulmonary hypertension of the newborn

💡 What You Need to Know

  • Definition: Persistent pulmonary hypertension of the newborn (PPHN) is a condition where the pulmonary vascular resistance remains abnormally high after birth, leading to right-to-left shunting of blood and severe hypoxemia.
  • Pathophysiology: Failure of the normal circulatory transition from fetal to neonatal life, characterized by persistent pulmonary vasoconstriction.
  • Key Feature: Blood bypasses the lungs through the foramen ovale and/or ductus arteriosus, resulting in poorly oxygenated systemic blood flow.
  • Incidence: Primarily affects term or near-term infants, often associated with underlying conditions.
  • Risk Factors: Perinatal asphyxia, meconium aspiration syndrome (MAS), sepsis, congenital diaphragmatic hernia (CDH), pneumonia, and maternal NSAID use late in pregnancy.

🤒 Associated Symptoms

  • Cyanosis: Central cyanosis, often severe and refractory to oxygen administration.
  • Tachypnea: Rapid breathing, indicating respiratory distress.
  • Increased Work of Breathing: Nasal flaring, retractions (subcostal, intercostal, suprasternal), and grunting.
  • Hypoxemia: Profoundly low oxygen saturation levels, often labile and fluctuating with minimal stimulation.
  • Differential Cyanosis: May be present if shunting occurs primarily through the ductus arteriosus (pre-ductal vs. post-ductal oxygen saturation differences).
  • Heart Murmur: A murmur of tricuspid regurgitation may be heard due to high right ventricular pressure.
  • Systemic Hypotension: Can occur due to poor cardiac output or effects of medications.
  • Metabolic Acidosis: Often present due to tissue hypoperfusion and anaerobic metabolism.

🛡 Crucial Precautions

  • Minimize Stimulation: Handle the infant gently and minimize environmental stimuli (noise, light) to prevent pulmonary vasoconstriction.
  • Maintain Normothermia: Ensure stable body temperature to reduce metabolic demand and prevent cold stress.
  • Optimize Ventilation: Carefully manage mechanical ventilation to achieve optimal lung inflation and promote pulmonary vasodilation without causing barotrauma.
  • Avoid Hypoxia and Acidosis: Promptly correct any episodes of hypoxemia or acidosis, as these exacerbate pulmonary vasoconstriction.
  • Fluid Management: Maintain strict fluid balance to prevent pulmonary edema while ensuring adequate systemic perfusion.
  • Sedation and Analgesia: Judicious use of sedatives and analgesics to reduce stress, pain, and oxygen consumption.
  • Monitor for Systemic Hypotension: Closely monitor blood pressure and intervene promptly to maintain adequate systemic perfusion pressure.
  • Prepare for iNO: Ensure readiness for inhaled nitric oxide (iNO) administration, a selective pulmonary vasodilator.

🍽 Dietary Directions & Restrictions

  • NPO Status: Infants with severe PPHN are typically kept nil per os (NPO) initially due to respiratory distress and the risk of necrotizing enterocolitis (NEC).
  • Parenteral Nutrition: Intravenous fluids and total parenteral nutrition (TPN) are initiated early to provide essential nutrients and maintain hydration.
  • Trophic Feeds: Minimal enteral feeds (trophic feeds) may be introduced cautiously once the infant is hemodynamically stable and respiratory status improves.
  • Breast Milk Preference: If enteral feeds are tolerated, breast milk is preferred due to its protective properties.
  • Monitoring for Intolerance: Closely monitor for signs of feeding intolerance, abdominal distension, or other indicators of NEC.
  • Gradual Advancement: Enteral feeds are advanced slowly and incrementally as the infant's condition allows.

⚠️ Attendant Guidelines

  • Continuous Monitoring: Implement continuous monitoring of heart rate, respiratory rate, oxygen saturation (pre- and post-ductal), blood pressure, and end-tidal CO2.
  • Blood Gas Analysis: Perform frequent arterial or capillary blood gas analyses to assess oxygenation, ventilation, and acid-base status.
  • Medication Titration: Administer and titrate pulmonary vasodilators (e.g., inhaled nitric oxide, sildenafil) and inotropes (e.g., dopamine, dobutamine) precisely as ordered.
  • Ventilator Checks: Regularly check ventilator settings and alarms, ensuring proper function and patient-ventilator synchrony.
  • Cluster Care: Organize care activities to minimize disturbances and allow for periods of uninterrupted rest.
  • ECMO Readiness: Be prepared for potential escalation to extracorporeal membrane oxygenation (ECMO) in cases of refractory PPHN.
  • Parental Communication: Provide clear, empathetic communication to parents regarding the infant's condition, treatment plan, and prognosis.

🩺 Physician's Perspective

  • Early Diagnosis: Prompt diagnosis, often confirmed by echocardiography, is crucial to differentiate PPHN from structural heart disease and guide therapy.
  • Multimodal Therapy: Management involves a comprehensive approach including optimizing oxygenation, ventilation, systemic blood pressure, and targeted pulmonary vasodilation.
  • Inhaled Nitric Oxide (iNO): Consider iNO as a first-line selective pulmonary vasodilator, carefully monitoring for response and potential side effects.
  • Systemic Support: Ensure adequate systemic blood pressure and cardiac output to maintain perfusion to vital organs, often requiring inotropic support.
  • Addressing Underlying Causes: Identify and treat any underlying conditions such as sepsis, meconium aspiration, or pneumonia.
  • ECMO Consideration: Timely referral to an ECMO center should be considered for infants who fail to respond to conventional medical therapies.
  • Neurodevelopmental Follow-up: Emphasize the importance of long-term neurodevelopmental follow-up due to the increased risk of adverse outcomes in survivors.

🎓 Academic & Nursing Corner

  • Fetal Circulation Review: Understand the unique aspects of fetal circulation and the normal transition at birth to grasp PPHN pathophysiology.
  • Assessment of Respiratory Distress: Develop keen skills in assessing and scoring neonatal respiratory distress, including subtle signs of worsening condition.
  • iNO Administration: Learn the principles of inhaled nitric oxide delivery, monitoring for methemoglobinemia, and weaning protocols.
  • Hemodynamic Monitoring: Interpret arterial line waveforms, central venous pressures, and understand their implications for PPHN management.
  • Fluid and Electrolyte Balance: Master the calculation and monitoring of fluid intake/output and electrolyte levels in critically ill neonates.
  • Parental Support: Practice providing compassionate and informative support to parents navigating the complexities of their infant's critical illness.
  • Ventilator Management Basics: Understand basic ventilator modes, settings, and how they impact pulmonary vascular resistance.

🔬 Clinical Reference Index

  • Echocardiography: Diagnostic tool to confirm PPHN, assess pulmonary artery pressures, shunt direction/magnitude, and rule out congenital heart disease.
  • Pre- and Post-Ductal Oxygen Saturations: Used to detect right-to-left shunting across the ductus arteriosus (e.g., right hand vs. foot sats).
  • Inhaled Nitric Oxide (iNO): A selective pulmonary vasodilator administered via the ventilator circuit.
  • High-Frequency Oscillatory Ventilation (HFOV): An advanced ventilation strategy often used to optimize lung recruitment and oxygenation in PPHN.
  • Extracorporeal Membrane Oxygenation (ECMO): A life support system providing temporary cardiac and/or respiratory support for severe, refractory cases.
  • Sildenafil: An oral phosphodiesterase-5 inhibitor used as a pulmonary vasodilator, sometimes as an adjunct or alternative to iNO.
  • Prostacyclin Analogs: Medications like epoprostenol or iloprost, which are potent pulmonary vasodilators, sometimes used in severe cases.
  • Cardiac Catheterization: Rarely performed for diagnosis, but can provide definitive hemodynamic measurements.